TY  - JOUR

T1  - Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II/III breast cancer.

JO  - Breast Cancer Res Treat

UR  - https://eprints.whiterose.ac.uk/153939/

PY  - 2011/03/11

AU  - Coleman R

AU  - Woodward E

AU  - Brown J

AU  - Cameron D

AU  - Bell R

AU  - Dodwell D

AU  - Keane M

AU  - Gil M

AU  - Davies C

AU  - Burkinshaw R

AU  - Houston SJ et al

ED  - 

DO  - DOI: 10.1007/s10549-011-1429-y

VL  - 127

IS  - 2

SP  - 429

EP  - 438

Y2  - 2024/12/21

ER  -